NNMT-driven metabolic reprogramming creates a NAMPT druggable vulnerability and reveals liquid biopsy biomarkers for TKI resistance in EGFR-mutant NSCLC.
Pulido I, García-Cañaveras JC, Rodríguez ML, Becker JH, López A, Aupí M, Aparisi S, Chuliá-Peris L, Tamayo-Torres E, Carreres-Rey C, Alcácer Fernández-Coronado J, Benet M, Montero S, Mena S, Sandoval J, Pereda J, Alcácer J, Calabuig-Fariñas S, Jantus-Lewintre E, Cremades A, Galbis-Caravajal JM, Martín-Martorell P, Insa A, Massad MG, Juan-Vidal O, Lahoz A, Shimamura T, Carretero J.
Pulido I, et al. Among authors: rodriguez ml.
Cancer Lett. 2025 Sep 9;633:218032. doi: 10.1016/j.canlet.2025.218032. Online ahead of print.
Cancer Lett. 2025.
PMID: 40935282
Free article.